7743.T
The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
Business. The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
The company's capital structure is characterized by a debt-to-equity ratio of 1.45, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current ratio of 1.14, suggesting that the company has sufficient short-term assets to cover its short-term liabilities, but with limited excess. The company's free cash flow is negative at -690,286,000 JPY, which may indicate that capital expenditures are outpacing operating cash flow.
In terms of profitability, the company's return on equity is 6.05%, which is a measure of how effectively the company is using shareholders' equity to generate profit. The return on assets of 2.11% suggests that the company is generating a relatively low return on its total assets. These metrics should be compared against the industry's preferred metrics and cohort medians to determine the company's relative performance.
The company's revenue is concentrated in the healthcare services and equipment industry, with no specific segment or geographic breakdown provided in the available data. This lack of diversification could pose a risk if the industry experiences a downturn or if regulatory changes impact the company's operations.
The company's growth trajectory is reflected in its recent financial performance, with a net income of 1,092,467,000 JPY and a revenue of 33,231,633,000 JPY. Analysts have estimated the mean revenue for the upcoming period at 34,000,000,000 JPY, indicating a slight increase in expected revenue. The company's ability to meet or exceed these estimates will be a key factor in its future performance.
The risk assessment indicates that the company faces a medium liquidity risk, with a current ratio of 1.14 and a negative free cash flow. The dilution risk is assessed as low, with no significant dilution potential reported. The company's capital structure, with a high debt-to-equity ratio, may also contribute to its risk profile, as it could be more vulnerable to interest rate fluctuations and economic downturns.
Recent events, such as the company's financial performance and analyst estimates, suggest that the company is maintaining a stable position in the market. The company's last actual EPS was 36.10 JPY, slightly above the mean EPS estimate of 34.00 JPY. This indicates that the company has met or exceeded analyst expectations in the most recent reporting period.
- The company has a moderate debt-to-equity ratio of 1.45, indicating a balanced capital structure.
- The company's return on equity is 6.05%, which is a measure of its profitability relative to shareholders' equity.
- The company's liquidity position is assessed as medium, with a current ratio of 1.14.
- The company's free cash flow is negative, which may indicate that capital expenditures are outpacing operating cash flow.
- The company's revenue is expected to increase slightly, with analysts estimating a mean revenue of 34,000,000,000 JPY for the upcoming period.
- margin_outlook_rationale: The company's gross profit margin is expected to remain stable, driven by consistent demand for medical equipment and supplies.
- rd_outlook_rationale: The company's research and development outlook is neutral, with no significant changes in R&D spending expected.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 34,00 |
| Revenue | —no estimate | —no estimate | 34,0B JPY |
| Operating income | —no estimate | —no estimate | —no estimate |
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- 7743.T Market data — financials · 2026-05-27
- Seed Co Ltd Market data — analyst estimates · 2026-05-27